Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $89
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Cuts Target Price to $86
RBC Capital Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $115
RBC Capital Reaffirms Their Buy Rating on Dexcom (DXCM)
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $94
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD) and Dexcom (DXCM)
Bernstein Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $150
Citigroup Raises DexCom Price Target to $91 From $85, Maintains Buy Rating
DexCom Analyst Ratings
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $94
Wells Fargo Remains a Buy on Dexcom (DXCM)
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Announces Target Price $90
DexCom Is Maintained at Buy by Canaccord Genuity
DexCom Analyst Ratings
CCORF Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $99
Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $90
Wells Fargo Sticks to Their Buy Rating for Dexcom (DXCM)
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Bank of America Securities Reaffirms Their Buy Rating on Dexcom (DXCM)